What is dabrafenib used for?

Dabrafenib is used alone or in combination with trametinib (Mekinist) to treat a certain types of melanoma (a type of skin cancer) that cannot be treated with surgery or that has spread to other parts of the body.

How does BRAF inhibitor work?

The BRAF inhibitors vemurafenib, dabrafenib and encorafenib are used in the treatment of patients with BRAF-mutant melanoma. They selectively target BRAF kinase and thus interfere with the mitogen-activated protein kinase (MAPK) signalling pathway that regulates the proliferation and survival of melanoma cells.

Why is trametinib used with dabrafenib?

The combination of dabrafenib and trametinib blocks the signaling pathway of the abnormal BRAF molecules. This action slows or stops the out-of-control cell growth: Dabrafenib targets the V600E-mutated BRAF molecule to block its signaling.

Can dabrafenib cure melanoma?

Through clinical trials, cancer researchers have found that combining dabrafenib and trametinib can treat advanced melanoma more effectively than either medication on its own. The combination also produces less serious side effects than the single drugs used alone.

Is Larotrectinib chemotherapy?

VITRAKVI® is an oral medicine that is not a chemotherapy.

How is dabrafenib mesylate used in the treatment of melanoma?

Dabrafenib mesylate is a methanesulfonate ( mesylate) salt prepared from equimolar amounts of dabrafenib and methanesulfonic acid. Used for treatment of metastatic melanoma. It has a role as an antineoplastic agent and a B-Raf inhibitor.

Which is the mesylate salt form of dabrafenib?

Dabrafenib Mesylate is the mesylate salt form of dabrafenib, an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene.

What is the mechanism of action of dabrafenib?

Mechanism of Action. Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the raf/mil family of serine/threonine protein kinases…

Can you take Dabrafenib alone or with trametinib?

Brand Name: Tafinlar. FDA Approval: Yes. Dabrafenib is approved to be used alone or with trametinibto treat: Anaplastic thyroid cancerin patients whose disease is locally advancedor has metastasized(spread to other parts of the body) and who cannot receive local treatment. It is used with trametinib.

What is Dabrafenib used for?

Dabrafenib is used alone or in combination with trametinib (Mekinist) to treat a certain types of melanoma (a type of skin cancer) that cannot be treated with surgery or that has spread to other parts of the body.

Is Dabrafenib a chemotherapy drug?

Dabrafenib is the generic name for the trade name chemotherapy drug Tafinlar. In some cases, health care professionals may use the trade name Tafinlar when referring to the generic drug dabrafenib. Drug type: Dabrafenib is a targeted therapy.

What is Dabrafenib and Trametinib?

Dabrafenib (Tafinlar®) and trametinib (Mekinst®) are targeted therapy drugs. They are given together to treat melanoma and non-small cell lung cancer.

Is Trametinib a chemotherapy drug?

Trametinib is the generic name for the trade name chemotherapy drug Mekinist. In some cases, health care professionals may use the trade name Mekinist when referring to the generic name trametinib. Drug type: Trametinib is a targeted therapy.

Does Keytruda make you sick?

Common side effects of KEYTRUDA when used alone include: feeling tired, pain, including pain in muscles, bones or joints, and stomach-area (abdominal) pain, decreased appetite, itching, diarrhea, nausea, rash, fever, cough, shortness of breath, and constipation.

How do you pronounce Dabrafenib?

dabrafenib

1. Genetic Implications:
2. Pronunciation: da-braf-e-nib.
3. Trade Name(s)
4. Ther. Class. antineoplastics.
5. Pharm. Class. kinase inhibitors.

Can dabrafenib be crushed?

Take this medicine at least 1 hour before or 2 hours after a meal. Swallow the capsule whole. Do not open, crush, or break it.

How do you store dabrafenib?

Storage

1. Store refrigerated at 2°C to 8°C (36°F to 46°F).
2. Brief (less than 24 hours) exposure to temperatures up to 30°C (86°F) is acceptable.

Can dabrafenib cure melanoma?

Through clinical trials, cancer researchers have found that combining dabrafenib and trametinib can treat advanced melanoma more effectively than either medication on its own. The combination also produces less serious side effects than the single drugs used alone.

How long can you take dabrafenib and trametinib?

When you have dabrafenib and trametinib For advanced cancer you take dabrafenib and trametinib for as long as they are working and the side effects aren’t too bad. If you’re having this combination of drugs to prevent melanoma skin cancer coming back after surgery, you take them for up to 12 months.

How do you stop KEYTRUDA itching?

If you have mild symptoms of an allergic reaction, such as a mild rash, call your doctor right away. They may suggest an over-the-counter antihistamine you can take by mouth, such as diphenhydramine (Benadryl), or a product you can apply to your skin, such as hydrocortisone cream, to manage your symptoms.

Can KEYTRUDA shrink tumors?

Pembrolizumab (Keytruda) is an immunotherapy medication that helps shrink tumors and helps patients with advanced melanoma live longer.

Which is the mesylate salt form of dabrafenib?

Dabrafenib Mesylate is the mesylate salt form of dabrafenib, an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene.

How is dabrafenib mesylate used in the treatment of melanoma?

Dabrafenib mesylate is a methanesulfonate ( mesylate) salt prepared from equimolar amounts of dabrafenib and methanesulfonic acid. Used for treatment of metastatic melanoma. It has a role as an antineoplastic agent and a B-Raf inhibitor.

What is the terminal half life of dabrafenib?

The average terminal half-life of dabrafenib is 8 hours after oral dosing. Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene.

How much dabrafenib is in a 50 mg capsule?

TAFINLAR (dabrafenib) capsules for oral use are supplied as 50 mg and 75 mg capsules for oral administration. Each 50 mg capsule contains 59.25 mg dabrafenib mesylate equivalent to 50 mg of dabrafenib free base.